Published in J Virol on November 01, 1991
Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A (1995) 2.79
High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol (2006) 2.74
3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J (2008) 2.67
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol (1999) 2.35
Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J Virol (1995) 1.57
Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression. PLoS One (2011) 1.46
The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region. J Virol (1995) 1.40
Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP. RNA (2000) 1.30
The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein. J Virol (1999) 1.21
A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J Virol (2005) 1.16
Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J Virol (2004) 1.16
Sequence of the polypyrimidine tract of the 3'-terminal 3' splicing signal can affect intron-dependent pre-mRNA processing in vivo. Nucleic Acids Res (1996) 1.14
A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc Natl Acad Sci U S A (1997) 1.10
Where do introns come from? PLoS Biol (2008) 1.10
The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res (2007) 1.07
Late promoter of human papillomavirus type 8 and its regulation. J Virol (1992) 1.06
Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J Virol (1999) 1.06
Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5' splice sites that bind a U1 snRNP-like complex. J Virol (2003) 1.05
Regulation of human papillomavirus gene expression by splicing and polyadenylation. Nat Rev Microbiol (2013) 1.04
Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol Cell Biol (2005) 1.03
The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element. J Virol (2002) 1.01
Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J Virol (2001) 1.00
A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J Virol (2005) 0.99
Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J Virol (2003) 0.98
Distance-dependent processing of adeno-associated virus type 5 RNA is controlled by 5' exon definition. J Virol (2007) 0.97
Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells. J Virol (1993) 0.95
The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region. Mol Cell Biol (1995) 0.95
Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS. Nucleic Acids Res (2003) 0.94
The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells. J Virol (1997) 0.94
Analysis of inhibitory action of modified U1 snRNAs on target gene expression: discrimination of two RNA targets differing by a 1 bp mismatch. Nucleic Acids Res (2002) 0.90
Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J Virol (1994) 0.89
Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation. Biochem Soc Trans (2008) 0.88
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation. Nucleic Acids Res (2007) 0.88
Analysis of transcripts from predicted open reading frames of Musca domestica salivary gland hypertrophy virus. J Gen Virol (2009) 0.85
Splicing-coupled 3' end formation requires a terminal splice acceptor site, but not intron excision. Nucleic Acids Res (2013) 0.84
U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate. RNA Biol (2013) 0.81
Regulation of bovine papillomavirus type 1 gene expression by RNA processing. Front Biosci (Landmark Ed) (2009) 0.80
The reciprocal regulation between splicing and 3'-end processing. Wiley Interdiscip Rev RNA (2016) 0.80
Ectopic 5' splice sites inhibit gene expression by engaging RNA surveillance and silencing pathways in plants. Plant Physiol (2009) 0.76
Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs. Int J Mol Sci (2017) 0.75
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene (1984) 56.23
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A (1981) 9.27
The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev (1989) 7.03
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J (1991) 6.00
Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria. Proc Natl Acad Sci U S A (1982) 5.22
Localization and analysis of bovine papillomavirus type 1 transforming functions. J Virol (1984) 4.77
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
mRNA decay: finding the right targets. Cell (1989) 3.31
Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol (1989) 3.26
Regulated mRNA stability. Annu Rev Genet (1990) 2.93
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci U S A (1991) 2.77
Control of the sperm-oocyte switch in Caenorhabditis elegans hermaphrodites by the fem-3 3' untranslated region. Nature (1991) 2.74
In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol (1986) 2.56
Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Inst (1980) 2.44
Sequences 5' to the polyadenylation signal mediate differential poly(A) site use in hepatitis B viruses. Genes Dev (1990) 2.43
Sequences upstream of AAUAAA influence poly(A) site selection in a complex transcription unit. Mol Cell Biol (1989) 2.33
A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol (1991) 1.95
Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo. J Virol (1990) 1.62
Differential regulation of papilloma virus early gene expression in transformed fibroblasts and carcinoma cell lines. EMBO J (1986) 1.35
Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells. J Virol (1989) 1.18
Promoters of bovine papillomavirus type 1: in vitro activity and utilization. J Virol (1988) 0.95
In vitro transcription of adenovirus. J Virol (1981) 7.06
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol (1987) 6.65
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell (1979) 5.28
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. J Mol Biol (1981) 5.01
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J (1987) 3.77
Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery (1983) 3.65
Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J Cell Biol (1989) 3.55
Epidemiology of trauma deaths. Am J Surg (1980) 2.58
Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol (1994) 2.49
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster. Mol Cell Biol (1998) 2.23
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
A comparison of the association of helicopter and ground ambulance transport with the outcome of injury in trauma patients transported from the scene. J Trauma (1997) 1.97
Changes in lymphocyte activity after thermal injury. The role of suppressor cells. J Clin Invest (1979) 1.94
The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA (2001) 1.94
Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing. Mol Ther (2001) 1.84
The genetics of bovine papillomavirus type 1. Annu Rev Genet (1988) 1.75
Acute appendicitis following blunt abdominal trauma. Incidence or coincidence? Ann Surg (1991) 1.72
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Predicting fatal sepsis in burn patients. J Trauma (1979) 1.54
Biogenesis, structures, and sites of encoding of the 5' termini of adenovirus-2 mRNAs. Cold Spring Harb Symp Quant Biol (1980) 1.52
The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock (1996) 1.46
Epidemiology of trauma: the civilian perspective. Ann Emerg Med (1986) 1.39
Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. J Virol (1996) 1.39
Cardiac contusion. The effect on operative management of the patient with trauma injuries. Arch Surg (1989) 1.37
A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. Proc Natl Acad Sci U S A (1998) 1.37
Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg (1986) 1.34
The role of emergency room thoracotomy in trauma. J Trauma (1980) 1.27
Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5'-noncoding region. J Med Virol (1995) 1.22
Cystoid macular edema in pseudophakia. Surv Ophthalmol (1984) 1.21
Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol (1993) 1.21
Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Neurology (1997) 1.20
Complementary deoxyribonucleic acid cloning of bovine transforming growth factor-beta 1. Mol Endocrinol (1987) 1.19
Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J Virol (1995) 1.16
Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma. J Trauma (1987) 1.12
Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis. Carcinogenesis (2005) 1.11
Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding. J Trauma (1994) 1.09
Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers. J Virol (1997) 1.09
Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo. J Virol (2000) 1.08
Nonoperative management of adult blunt splenic trauma. Criteria for successful outcome. Ann Surg (1989) 1.04
An analysis of the association of trauma centers with per capita hospitalizations and death rates from injury. Ann Surg (1993) 1.04
Accuracy of administrative data in trauma. Surgery (1999) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
Intraocular lenses: complications and visual results. Trans Am Ophthalmol Soc (1983) 0.98
Identity of mononuclear cells which compromise the resistance of trauma patients. J Surg Res (1979) 0.98
Comparison of the ability of adult and pediatric trauma scores to predict pediatric outcome following major trauma. J Trauma (1991) 0.98
A statewide, population-based time-series analysis of the increasing frequency of nonoperative management of abdominal solid organ injury. Ann Surg (1995) 0.96
Management outcomes in splenic injury: a statewide trauma center review. Ann Surg (1997) 0.96
Promoters of bovine papillomavirus type 1: in vitro activity and utilization. J Virol (1988) 0.95
Vascular injuries in a rural state: a review of 978 patients from a state trauma registry. J Trauma (1992) 0.95
The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region. Mol Cell Biol (1995) 0.95
15's: they fit in everywhere--especially the school bag: a survey of purchases of packets of 15 cigarettes by 14 and 15 year olds in South Australia. Community Health Stud (1987) 0.94
On the analysis of circular dichroic spectra of proteins. Biochemistry (1976) 0.94
Pancreatic injuries resulting from penetrating trauma: a multi-institution review. Am Surg (1998) 0.93
Impact of a trauma service on trauma care in a university hospital. Am J Surg (1985) 0.93
The impact of laparoscopic cholecystectomy on the management and outcome of biliary tract disease in North Carolina: a statewide, population-based, time-series analysis. J Am Coll Surg (1996) 0.93
Accuracy of administrative data in trauma: splenic injuries as an example. J Trauma (2000) 0.92
Thoracic aorta injuries: management and outcome of 144 patients. J Trauma (1996) 0.91
Postexposure immunoprophylaxis against B virus infection. Br Med J (Clin Res Ed) (1982) 0.91
A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 0.91
Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site. J Virol (1999) 0.91
Management of acute cervicothoracic vascular injuries. J Thorac Cardiovasc Surg (1980) 0.90
Multivariate population-based analysis of the association of county trauma centers with per capita county trauma death rates. J Trauma (1992) 0.90
Defective antigen presentation to a cloned T helper cell by macrophages from burned mice can be restored with interleukin-1. Surgery (1985) 0.90
Management and outcome of abdominal shotgun wounds. Trauma score and the role of exploratory laparotomy. Ann Surg (1995) 0.90
The human burn wound as a primary source of interleukin-1 activity. Surgery (1986) 0.88
Ethnic differences in accident rates at work. Br J Ind Med (1987) 0.88
Acute Physiology and Chronic Health Evaluation (APACHE II) score and outcome in the surgical intensive care unit: an analysis of multiple intervention and outcome variables in 1,238 patients. Crit Care Med (1991) 0.87
Fracture-dislocation of the lumbosacral spine: case report and review of the literature. J Trauma (1992) 0.87
Field triage of trauma patients based upon the ability to follow commands: a study in 29,573 injured patients. J Trauma (1995) 0.86
A population-based study of the association of medical manpower with county trauma death rates in the United States. Ann Surg (1994) 0.85
Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs. J Virol Methods (2000) 0.84
Toxoplasmosis, an innocuous disease? J Infect (1984) 0.84
Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique. Proc Natl Acad Sci U S A (2000) 0.84
Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock (2000) 0.84
A burn induced Ly-2 suppressor T cell lowers resistance to bacterial infection. J Surg Res (1985) 0.84
Proinflammatory kupffer cell alterations after femur fracture trauma and sepsis in rats. Shock (2000) 0.83
An objective analysis of process errors in trauma resuscitations. Acad Emerg Med (2000) 0.83
A new posterior chamber intraocular lens formula for axial myopes. Ophthalmology (1984) 0.82
Correlation of traumatic shock with immunocompetence and sepsis. Surg Forum (1979) 0.81
The effect of tuftsin and splenectomy on mortality after intraabdominal sepsis. J Surg Res (1984) 0.81
A computerized analysis of astigmatism after cataract surgery. Ophthalmic Surg (1986) 0.81
Septic phlebitis: a neglected disease. Am J Surg (1979) 0.80
Failure of penicillin prophylaxis in laboratory acquired leptospirosis. Postgrad Med J (1988) 0.80
Clarification of the role of CT scan in the acute evaluation of blunt abdominal trauma. Conn Med (1991) 0.80
Sp1 is critical for basal and E2-transactivated transcription from the bovine papillomavirus type 1 P89 promoter. J Gen Virol (1996) 0.80
Terminal B-cell maturation and immunoglobulin (Ig) synthesis in vitro in patients with major injury. J Trauma (1989) 0.80
Immune mechanisms and host resistance in the trauma patient. Yale J Biol Med (1986) 0.79
A case of good management. J Infect (1983) 0.79
Headache due to spontaneous low spinal fluid pressure. Minn Med (1983) 0.79
Prospective comparison of clinical judgment and APACHE II score in predicting the outcome in critically ill surgical patients. J Trauma (1992) 0.79
Effect of resuscitation with hydroxyethyl starch and lactated Ringers on macrophage activity after hemorrhagic shock and sepsis. Shock (1994) 0.78
A simple method of predicting severe sepsis in burn patients. Am J Surg (1980) 0.78
Special feature: pathological case of the month. Diagnosis and discussion: neurofibromatosis 2 with bilateral vestibular schwannomas and spinal cord ependymoma. Arch Pediatr Adolesc Med (2000) 0.78
Acute cholecystitis complicating ERCP: a case report. J Clin Gastroenterol (1988) 0.78
Pitfalls in the diagnosis and management of blunt splenic trauma. Conn Med (1986) 0.77